Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?

<p>Abstract</p> <p>Background</p> <p>Pulmonary arterial hypertension (PAH) has witnessed dramatic treatment advances over the past decade. However, with the exception of epoprostenol, data from short-term randomized controlled trials (RCTs) have not shown a benefit of t...

Full description

Bibliographic Details
Main Authors: Stewart Simon, Dalton Brad, Wlodarczyk John, Strange Geoff, Steele Peter, Gabbay Eli, Keogh Anne
Format: Article
Language:English
Published: BMC 2010-02-01
Series:BMC Cardiovascular Disorders
Online Access:http://www.biomedcentral.com/1471-2261/10/9

Similar Items

Similar Items